Your browser doesn't support javascript.
loading
The Effect of Fasting on Body Composition Assessment in Hospitalized Cancer Patients.
Artero, Ana; Sáez Ramírez, Teresa; Muresan, Bianca Tabita; Ruiz-Berjaga, Yesica; Jiménez-Portilla, Ana; Sánchez-Juan, Carlos J.
Afiliação
  • Artero A; Departamento de Medicina, Universitat de Valencia, Valencia, Spain.
  • Sáez Ramírez T; Departamento de Medicina, Universitat de Valencia, Valencia, Spain.
  • Muresan BT; Valencian International University (VIU), Valencia, Spain.
  • Ruiz-Berjaga Y; Departamento de Medicina, Universitat de Valencia, Valencia, Spain.
  • Jiménez-Portilla A; Departamento de Medicina, Universitat de Valencia, Valencia, Spain.
  • Sánchez-Juan CJ; Departamento de Medicina, Universitat de Valencia, Valencia, Spain.
Nutr Cancer ; 75(8): 1610-1618, 2023.
Article em En | MEDLINE | ID: mdl-37350672
ABSTRACT
Guidelines for bioelectrical impedance analysis (BIA) recommend fasting before measurements, but how it affects the outcomes is unclear. This descriptive, before-and-after study examines the effect of fasting on BIA results and its impact on the diagnosis of malnutrition in hospitalized cancer patients. Fifty-three oncology patients (admitted in January-March 2020) were consecutively enrolled regardless of their nutritional status. Patients were assessed by the same dietician 24-48 h after admission, following the usual clinical practice. The measurements were taken after 12-h fasting (fasting state) and 60-90 min after breakfast (non-fasting state). Bioimpedance parameters (resistance [R], reactance [Xc], phase angle [PA]) and body composition indices (free-fat mass index [FFMI] and appendicular skeletal muscle index [ASMI]) were calculated. On average, R values did not significantly differ between fasting and non-fasting states (mean difference +1.82 Ω; p = 0.64). The non-fasting Xc and PA were reduced (mean differences -1.55 Ω, p = 0.93 and 0.09°, p = 0.82, respectively). Fasting and non-fasting FFMI and ASMI were similar (mean differences -0.13 kg/m2 (p = 0.5) and -0.10 kg/m2 (p not calculated)). These results suggest that BIA does not require fasting, facilitating its routine use in hospitalized cancer patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desnutrição / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desnutrição / Neoplasias Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article